Rainbow Coral (RBCC) is spearheading the most innovative scientific and medical breakthroughs in the $84.6 billion global biotechnology industry, and is focused on bringing new deals to investors by year-end. The company and its joint venture partners continue to market and develop breakthrough innovations, currently focused on 3D printing technology and substance abuse treatment.